Updated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitution, and emerging uses in sepsis and immunodeficiency.
Key findingUpdated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitutio
What the researchers found
Updated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitution, and emerging uses in sepsis and immunodeficiency.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
From lab to bedside: emerging clinical applications of thymosin alpha 1.
Expert opinion on biological therapy, 9(5), 593-608
Citation
Goldstein, Allan L; Goldstein, Adam L. (2009). From lab to bedside: emerging clinical applications of thymosin alpha 1.. Expert opinion on biological therapy, 9(5), 593-608. https://doi.org/10.1517/14712590902911412